Image capture and ordering
US-9712746-B2 · Jul 18, 2017 · US
US12285277B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12285277-B2 |
| Application number | US-202418614944-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 25, 2024 |
| Priority date | Feb 13, 2013 |
| Publication date | Apr 29, 2025 |
| Grant date | Apr 29, 2025 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A method of generating corrected fluorescence data of concentrations of a targeted fluorophore in tissue of a subject includes administering first and second fluorescent contrast agents to the subject, the first contrast agent targeted to tissue of interest, the second agent untargeted. The tissue is illuminated with light of a first stimulus wavelength and first data is acquired at an appropriate emissions wavelength; the tissue is illuminated at a second stimulus wavelength and second data is acquired at a second emissions wavelength associated with the second agent, the first and second emissions wavelength differ. Difference data is generated by subtracting the second data from the first data. A system provides for stimulus and capture at multiple wavelengths, with image storage memory and subtraction code, to perform the method. Corrected data may form an fluorescence image, or is used to generate fluorescence tomographic images.
Opening claim text (preview).
What is claimed is: 1. A system for generating three dimensional images of bound fluorophore concentrations in tissue comprising: a first apparatus configured for generating and illuminating tissue with light selectable between a nontargeted stimulus wavelength and a targeted stimulus wavelength; a photodetector apparatus adaptable to capture nontargeted emissions data at nontargeted emission wavelengths from a nontargeted fluorophore in the tissue while the tissue is illuminated with light of the nontargeted stimulus wavelength, and to capture targeted emissions data at targeted emission wavelengths from a targeted fluorophore in the tissue while the tissue is illuminated with light of the targeted stimulus wavelength, where at least the nontargeted emission wavelengths and the targeted emissions wavelengths are different; a memory configured to store the nontargeted emissions data and the targeted emissions data; a processor configured with machine readable code in the memory; the machine readable code comprising instructions for reconstructing bound fluorophore concentrations of a voxel-based three dimensional model of distribution of bound targeted fluorophore concentration in tissue from difference data derived by subtracting the nontargeted emissions data from the targeted emissions data. 2. The system of claim 1 wherein the machine readable code comprises instructions to scale an emissions data selected from the group selected from the nontargeted emissions data and the targeted emissions data prior to subtracting the nontargeted emissions data from the targeted emissions data. 3. The system of claim 2 where the nontargeted stimulus wavelength and the targeted stimulus wavelength are different wavelengths. 4. The system of claim 3 where the nontargeted stimulus wavelength and the targeted stimulus wavelength are provided to the tissue sequentially. 5. The system of claim 3 where the nontargeted stimulus wavelength and the targeted stimulus wavelength are provided to the tissue simultaneously. 6. The system of claim 2 further comprising a stereo camera, and where the machine readable instructions in memory further comprise instructions for extracting a three-dimensional surface model from images obtained by the stereo camera, and where the voxel-based three-dimensional model of distribution of bound targeted fluorophore concentration in tissue is conformed to the three-dimensional surface model. 7. The system of claim 2 wherein a camera of the system is configurable to obtain a white-light image of the tissue and wherein the machine readable instructions in the memory comprise instructions for color-coding the bound fluorophore concentration data and superimposing the color-coded bound fluorophore concentration data on the white-light image of the tissue. 8. A method of generating bound targeted fluorophore concentration data in tissue of a subject comprising: illuminating tissue of the subject with light of a targeted stimulus wavelength; acquiring targeted data at a first emissions wavelength associated with a targeted fluorophore in the tissue of the subject, the targeted fluorophore in the tissue of the subject selected from the group consisting of a tissue-targeting agent coupled to a fluorophore and a fluorophore generated by the tissue of the subject by metabolizing a tissue-targeted prodrug; illuminating tissue of the subject with light of a nontargeted stimulus wavelength; acquiring nontargeted data at a nontargeted emissions wavelength associated with a nontargeted fluorophore in tissue of the subject; scaling a data selected from the nontargeted data and the targeted data; subtracting the nontargeted data from the targeted data to provide a corrected fluorescence data; and reconstructing the bound fluorophore concentration data using a voxel-based three dimensional model of tissue distribution of the bound targeted fluorophore concentration in tissue from the corrected fluorescence data; wherein the targeted fluorophore emits light of the targeted emissions wavelength when stimulated by light of the targeted stimulus wavelength, and the nontargeted fluorophore emits light of the nontargeted emissions wavelength when stimulated by light of the nontargeted stimulus wavelength; and wherein the targeted emissions wavelength differs from the nontargeted emissions wavelength. 9. The method of claim 8 where the nontargeted stimulus wavelength and the targeted stimulus wavelength are different wavelengths. 10. The method of claim 9 where the nontargeted stimulus wavelength and the targeted stimulus wavelength are provided to the tissue sequentially. 11. The method of claim 10 further comprising: obtaining a white-light image of the tissue; color-coding the bound fluorophore concentration data; and superimposing the color-coded bound fluorophore concentration data on the white-light image of the tissue. 12. The method of claim 11 wherein the targeted fluorophore is an antibody coupled to a fluorophore. 13. The method of claim 11 wherein the targeted fluorophore is a fluorophore generated by tissue of the subject. 14. The method of claim 9 where the nontargeted stimulus wavelength and the targeted stimulus wavelength are provided to the tissue simultaneously. 15. The method of claim 8 where the nontargeted stimulus wavelength and the targeted stimulus wavelength are the same. 16. The method of claim 8 further comprising: obtaining a white-light image of the tissue; color-coding the bound fluorophore concentration data; and superimposing the color-coded bound fluorophore concentration data on the white-light image of the tissue. 17. The method of claim 8 further comprising: obtaining scan images selected from the group of magnetic resonance imaging (MRI) images and computed tomography (CT) images; registering the bound fluorophore concentration data to the scan images color-coding the bound fluorophore concentration data; and superimposing the color-coded bound fluorophore concentration data on the scan images. 18. The method of claim 17 further comprising adjusting the scan images for intraoperative tissue and tumor displacement. 19. The method of claim 8 wherein the targeted fluorophore comprises a fluorophore produced by the tissue by metabolizing a prodrug.
Antibodies · CPC title
Medical imaging apparatus involving image processing or analysis (A61B1/00009, A61B6/52 and A61B8/52 take precedence) · CPC title
adapted for acquisition of images from more than one imaging mode, e.g. combining MRI and optical tomography · CPC title
Arrangements for scanning · CPC title
by measuring fluorescence emission · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.